The Effect of Yoga and Stabilization Exercises in Individuals With Chronic Low Back Pain
19 de outubro de 2021 atualizado por: Ozlem Ulger, Hacettepe University
The Effect of Yoga and Stabilization Exercises on Pain, Functional Status, Metabolic Capacity and Sleep Quality in Individuals With Chronic Low Back Pain: A Randomized, Crossover Study.
Although exercise has been shown to be effective in low back pain in the literature, there is no conclusion about which exercise is superior to the other.
Although there are studies showing positive effects of spinal stabilization exercises and yoga approach on pain level, disability level and quality of life in patients with chronic low back pain, studies evaluating the effectiveness in many other aspects are insufficient.
Therefore, this study aimed to investigate the effects of spinal stabilization and yoga exercises on pain, functional status, metabolic capacity, kinesophobia and sleep quality in patients with chronic low back pain.
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Tipo de estudo
Intervencional
Inscrição (Real)
28
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Altındağ
-
Ankara, Altındağ, Peru, 06100
- Özlem Ülger
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
25 anos a 65 anos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- Chronic non-specific low back pain diagnosis
- Having pain that persists for at least 12 weeks
- 25-65 age range
Exclusion Criteria:
- Scoliosis with a cobb angle of more than 20º
- History of previous surgery for the lumbal region
- Having an additional diagnosis such as spondylolisthesis, spinal stenosis, spondylolysis
- Presence of neurological deficits
- Metastatic state presence
- Presence of neurological deficits due to diabetes
- Presence of metabolic problems such as thyroid, hypertension, coronary artery disease
- The presence of inflammatory problems involving the spine
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição cruzada
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Yoga Group
The sessions will begin with breathing exercises in standing, sitting, supine and prone positions, and these exercises will be applied for about 10 minutes.
After the breathing exercises, the sudden relaxation technique, which will take 2-3 minutes, firstly contracting the whole body from the feet to the head and then completely relaxing it.
|
Yoga
|
|
Experimental: Spinal Stabilization Exercise Group
Spinal stabilization exercises will be applied to the individuals in this group for 8 weeks / 2 days a week, approximately 50-60 minutes a day under the supervision of a physiotherapist. Spinal stabilization exercises will be progressed in 3 phases by gradually increasing the difficulty. |
Spinal Stabilization Exercise
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Pain Intensity
Prazo: 15 minutes, through study completion, an average of 8 weeks, Change from pain intensity
|
Pain intensity of participants will be evaluated with visual analog scale (VAS).
Paricipants asked to mark the intensity of pain on a 10 cm long line, explaining that the leftmost of the line does not have pain, that the pain increases while moving to the right, and that the pain is unbearable on the far right.
VAS scored between 0-10 cm.
|
15 minutes, through study completion, an average of 8 weeks, Change from pain intensity
|
|
Disability Severity
Prazo: 5 minutes, through study completion, an average of 8 weeks, Change from disability
|
Patient's pain related functional status will be measured by Oswestry Disability Index. The scale is considered the 'gold standard' of low back functional outcome tools. This scale contain questions related to functional activities of pain intensity, personal care, lifting, walking, sitting, standing, sleeping, sex life, social life and travelling. Interpretation of scale are 0% to 20% for minimal disability, 21% to 40% for moderate disability, 41 % to 60 % for severe disability 61% to 80 % for crippled and 81 % to 100 % Bed-bound. The Oswestry Disability Index is scored between 0-50 points. An increase in score indicates a poor result. Patient's back-related functional performance will be evaluated with Back Performance Scale. Each question is scored between 0 and 3. The total score recorded. The Back Performance Scale test is scored between 0-15 points. An increase in score indicates a poor result. |
5 minutes, through study completion, an average of 8 weeks, Change from disability
|
|
Funcitonal Performance
Prazo: 10 minutes, through study completion, an average of 8 weeks, Change from Functional status and performance
|
Patient's back-related functional performance will be evaluated with Back Performance Scale.
Each question is scored between 0 and 3.
The total score recorded.
The Back Performance Scale test is scored between 0-15 points.
An increase in score indicates a poor result.
|
10 minutes, through study completion, an average of 8 weeks, Change from Functional status and performance
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Deep muscle activation
Prazo: 5 minutes, through study completion, an average of 8 weeks, Change from deep muscle activation
|
To evaluate the transversus abdominis muscle activation, the stabilizer biofeedback device is placed under the abdomen, just below the spina iliaca anterior superior, while the patient is in the prone position.
The cuff of the device is inflated to 70 mmHg, the patient is asked to breathe and pull the abdomen up and in while exhaling, but the patient is warned not to make pelvis and spine movement.
In the meantime, how much the pressure has changed is observed from the stabilizer device.
In the test, the average of 3 repetitions will be recorded.
With successful measurement, the pressure is expected to drop between 6 and 10 mm-Hg.
|
5 minutes, through study completion, an average of 8 weeks, Change from deep muscle activation
|
|
Kinesiophobia
Prazo: 5 minutes, through study completion, an average of 8 weeks, Change from kinesiophobia
|
Fear-Avoidance-Beliefs Questionnaire will be applied to evaluate kinesiophobia which is fear of movement due to low back pain.
This questionnaire has 2 sub-sections related to physical activity and work.
There are 4 questions scored in the physical activity section and 7 questions in the work section.
0-6 points are obtained for each question.
The total score will be recorded.
Physical Activity sub-section scored between 0-24 points.
Work sub-sections scored between 0-42 points.
The higher the score, the higher the kinesiophobia.
|
5 minutes, through study completion, an average of 8 weeks, Change from kinesiophobia
|
|
Sleep quality
Prazo: 5 minutes, through study completion, an average of 8 weeks, Change from Baseline sleep quality
|
The Pittsburg Sleep Quality Index will be used to evaluate sleep quality.
This questionnaire evaluates sleep quality and disturbance over the past month.
The scale consists of 7 subcomponents: Subjective Sleep Quality, Sleep Latency, Sleep Duration, Habitual Sleep Efficiency, Sleep Disturbances, Use of Sleeping Medication, and Daytime Dysfunction.
Each component is scored between 0-3 points.
The total score of the 7 components gives the total score of the scale.
The total score ranges from 0-21.
A total score greater than 5 indicates "poor sleep quality".
|
5 minutes, through study completion, an average of 8 weeks, Change from Baseline sleep quality
|
|
Metabolic Capacity
Prazo: 15 minutes, through study completion, an average of 8 weeks, Change from Baseline metabolic capacity.
|
Metabolic capacity evaluation will be performed according to 6 Minute Walk Test.
Individuals are asked to walk as fast as possible for 6 minutes without running on the 30 m long corridor.
The test is started, the number of rounds is recorded while the patient is walking.
Heart rate, blood pressure, oxygen saturation and respiratory frequency will be evaluated and recorded at first, at the end of the test and one minute after.
Walking distance is recorded in meters.
|
15 minutes, through study completion, an average of 8 weeks, Change from Baseline metabolic capacity.
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Ozlem Ulger, Prof, Hacettepe University
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
15 de fevereiro de 2021
Conclusão Primária (Real)
15 de agosto de 2021
Conclusão do estudo (Real)
15 de agosto de 2021
Datas de inscrição no estudo
Enviado pela primeira vez
8 de fevereiro de 2021
Enviado pela primeira vez que atendeu aos critérios de CQ
5 de março de 2021
Primeira postagem (Real)
8 de março de 2021
Atualizações de registro de estudo
Última Atualização Postada (Real)
20 de outubro de 2021
Última atualização enviada que atendeu aos critérios de controle de qualidade
19 de outubro de 2021
Última verificação
1 de outubro de 2021
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- KA-20031
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Descrição do plano IPD
No.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .